Arcadia Biosciences
RKDA
RKDA
19 hedge funds and large institutions have $2.82M invested in Arcadia Biosciences in 2020 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more ownership
Funds ownership: 0.2% → 0.21% (+0%)
37% less call options, than puts
Call options by funds: $88K | Put options by funds: $139K
Holders
19
Holding in Top 10
–
Calls
$88K
Puts
$139K
Top Buyers
| 1 | +$696K | |
| 2 | +$417K | |
| 3 | +$68.6K | |
| 4 |
Wells Fargo
San Francisco,
California
|
+$29.4K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$18.6K |
Top Sellers
| 1 | -$612K | |
| 2 | -$7.22K | |
| 3 | -$7K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$3.84K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$2.14K |